Patient-reported outcomes following 24 weeks of treatment with upadacitinib in adults with non-segmental vitiligo: results from a phase 2, randomized, double-blind, dose-ranging study
BRITISH JOURNAL OF DERMATOLOGY（2024）
关键词
non-segmental vitiligo,upadacitinib,Janus kinase inhibitor,HRQoL
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要